Gene therapy ethics CER
Do now
Submit a complete gene therapy ethics CER weighing benefit against off-target and heritability risks.
- Hand in
- Complete gene therapy ethics CER: claim on whether the case patient should receive therapy, two evidences from vector chart and CRISPR work, reasoning naming one risk.
- Where
- Turn this in at the drop folder with your district Microsoft sign-in, or hand it to Mr. Mendoza in class. Both count as submitted. Doing the activity in myPLTW does not.
You get two school days for every day you were absent, so this deadline moves with you.
A specific patient could receive that might cure their disease, but the same therapy carries risk and, if , heritability risk. Do you recommend they receive it, and how do you defend that call when the outcome is not fully predictable?
Submit a complete ethics CER weighing benefit against and heritability risks.
- • You'll be able to write a complete, evidence-based CER.
- • You'll be able to weigh benefit against and heritability risk.
- What are the two main risk categories you have to weigh in a ethics argument this week?
- What are the three parts every CER needs?
- 1Combine your vector chart and notes into the evidence for one CER.
- 2Write your final claim on whether the case patient should receive the .
- 3Support it with two pieces of evidence and reasoning that names one risk.
- 4Submit your ethics CER for the week-end summative.
What did this day actually feel like?
Gene therapy ethics CER
A full CER on where the line sits. Mine argued somatic yes, germline not yet, and had to define not yet in a way that was not just avoidance.
Turned in: CER → Claim Evidence Reasoning folder
Fiction. There is no such student. The lessons, labs and dates are the real planned course; the student, the classmates and the conversations are invented.
The same day, drawn.
A full CER on where the line sits. Mine argued somatic yes, germline not yet, and had to define not yet in a way that was not just avoidance.
Fiction. There is no such student. The lessons, labs and dates are the real planned course; the student, the classmates and the conversations are invented.
🛠 Get unstuck · pick your level
🔑 Today's words · 5
Tap a word in the lesson for a plain meaning and one example. Recycled into next week's Do-Now.
Do the work · 80-minute blockfirst 5 min = hook▸
💡 Big idea: carries risks we cannot fully predict, so a recommendation is only defensible when it names the benefit, names the risk, and shows the reasoning that tips the balance.
- 0-15Assemble evidence: pull two strongest points from vector chart and annotation
- 15-50Write final ethics CER: claim on patient recommendation, two evidences, reasoning naming one risk
- 50-65: verify reasoning names a specific risk ( or heritability)
- 65-75Revise based on peer note; finalize
- 75-78Submit ethics CER
- 78-80Teacher confirms unit complete; preview unit2-synthesis
- • Hook: Return to the debate claim from Monday and ask: does your annotation change your position?
- • Why it matters: Clinicians and ethicists write exactly this kind of benefit-vs.-risk CER when advising policy.
- • Today's structure: 15 min evidence assembly, 35 min CER writing, 20 min and revision, 10 min final submit.
- • Exit goal: Complete ethics CER submitted before the bell.
- • A strong ethics CER names the benefit, the risk, and the reasoning that tips the balance one way.
- • edits and heritability (for therapies) are the two primary risk categories in ethics.
- • This synthesis connects Molecular and Genetic Technology and Biotech Research domains of WebXam 072130.
Gene therapy, viral vectors, somatic vs. germline editing, CRISPR basics, reproductive screening. · ethics CER
Day 4 of this lesson. Open this exact section in myPLTW (find it in Clever, Microsoft sign-in), then do the work below.
Do this: Open the gene-therapy unit summative in myPLTW and confirm all Activities 2.2.1 and 2.2.2 are marked complete before submitting your ethics CER.
Mark the ethics CER activity complete after submission.
annotation and CER should be done (Thursday); gene-therapy unit at 100% today.
Screenshot of completed gene-therapy unit progress page as your summative artifact.
The official PLTW activity stays inside myPLTW. If myPLTW will not open, use F1 and E1-E3 on this page to complete today's local evidence decision, then make up the official activity when access returns. Turn this in at the drop folder with your district Microsoft sign-in, or hand it to Mr. Mendoza in class. Both count as submitted. Doing the activity in myPLTW does not.
Check things off as you work, then submit. This tells Mr. Mendoza how you're doing so he can help the class. It does not replace turning in your producible through the submission route shown below.
Use the code Mr. Mendoza gave you, not your name. Saved on this device.
Gene therapy, viral vectors, somatic vs. germline editing, CRISPR basics, reproductive screening. · Gene therapy ethics CER
Open the gene-therapy unit summative in myPLTW and confirm all Activities 2.2.1 and 2.2.2 are marked complete before submitting your ethics CER.
annotation and CER should be done (Thursday); gene-therapy unit at 100% today.
This is how Mr. Mendoza sees the class keeping pace with PLTW. Be honest, it only helps if it is accurate.
🎯 Submit a complete ethics CER weighing benefit against and heritability risks.
- Combine your vector chart and notes into the evidence for one CER.
- Write your final claim on whether the case patient should receive the .
- Support it with two pieces of evidence and reasoning that names one risk.
- Submit your ethics CER for the week-end summative.
CER: Complete ethics CER: claim on whether the case patient should receive therapy, two evidences from vector chart and work, reasoning naming one risk.
Turn this in at the drop folder with your district Microsoft sign-in, or hand it to Mr. Mendoza in class. Both count as submitted. Doing the activity in myPLTW does not. Use the checklist just below and upload by 11:29 PM for full credit. Absent with an excused absence? You get two school days for every day you were absent, so this deadline moves with you.
| Task | Who |
|---|---|
| Combine your vector chart and notes into the evidence for one CER. | _______ |
| Write your final claim on whether the case patient should receive the . | _______ |
| Support it with two pieces of evidence and reasoning that names one risk. | _______ |
| Submit your ethics CER for the week-end summative. | _______ |
Working solo? Put your own name in "Who" for every row.
- You'll be able to write a complete, evidence-based CER.
- You'll be able to weigh benefit against and heritability risk.
- 1Do thisSubmit a complete gene therapy ethics CER weighing benefit against off-target and heritability risks.
- 2Use this resource
- 3Submit thisCER: Complete gene therapy ethics CER: claim on whether the case patient should receive therapy, two evidences from vector chart and CRISPR work, reasoning naming one risk.
- 4Submit it here
- 1Open the drop folder.
- 2Sign in with your district Microsoft account, not a personal one.
- 3Upload the file, named Lastname_Firstname__Assignment Title.
- 4Your own upload panel says Uploaded with a green check: that is your receipt.
Turn this in at the drop folder with your district Microsoft sign-in, or hand it to Mr. Mendoza in class. Both count as submitted. Doing the activity in myPLTW does not. Genetics of Disease (Medical Interventions) › Gene therapy, viral vectors, somatic vs. germline editing, CRISPR basics, reproductive screening. › CEROpen the drop folder
Learn it · deck, reading, and vocabulary▸
The deck carries the prior idea forward, lets you inspect an analogy, maps the rule to biology, and ends with the same evidence decision and exit ticket used on this page.
Generated from this lesson's canonical data with a red-team citation check.
A short guide RNA can match more than one spot in a 3-billion-letter genome, so Cas9 can cut and break a gene that was keeping the cell safe.
carries risks we cannot fully predict, so a recommendation is only defensible when it names the benefit, names the risk, and shows the reasoning that tips the balance.
A library keeps a master plan protected while working copies guide production at different stations.
- Why protect the master copy?
- What information moves?
- Where can an error change the final product?
Stored information can be copied, read, and converted into a functional product.
Genes are regulated biological sequences, not conscious instructions, and one gene rarely determines a whole trait alone.
- • Master plan maps to DNA.
- • Working copy maps to RNA.
- • Production output maps to or a regulated cell function.
Driving question: A specific patient could receive that might cure their disease, but the same therapy carries risk and, if , heritability risk. Do you recommend they receive it, and how do you defend that call when the outcome is not fully predictable?
What you already know: A short guide RNA can match more than one spot in a 3-billion-letter genome, so Cas9 can cut and break a gene that was keeping the cell safe.
New idea: carries risks we cannot fully predict, so a recommendation is only defensible when it names the benefit, names the risk, and shows the reasoning that tips the balance.
Visual or model: F1. F1. A lesson illustration or teaching diagram for Gene therapy ethics CER. Use it with E1-E3; it is a model or context image, not experimental or patient data. What to notice: Trace the labeled testing, treatment, or biological process and identify where evidence limits the decision.
- Observe or measure the relevant feature in ethics CER.
- Organize the observation with a stable evidence ID.
- Apply this rule: Stored information can be copied, read, and converted into a functional product.
- Choose the option the evidence supports and state the limit of the conclusion.
Real biomedical example: A specific patient could receive that might cure their disease, but the same therapy carries risk and, if , heritability risk. Do you recommend they receive it, and how do you defend that call when the outcome is not fully predictable?
What the evidence supports: E1-E3 and F1 support the daily take-home when the response meets the stated success criteria.
What it cannot prove: The package does not support claims beyond this lesson's or any real patient diagnosis.
- • : Treating disease by adding, silencing, or correcting a gene in a patient's cells.
- • vector: A that delivers genetic material into a cell, such as a or virus, or an organism like a mosquito that spreads a disease.
- • : A gene-editing tool that uses a guide RNA to steer the Cas9 to a chosen DNA site and cut it, so a sequence can be changed.
- • : Relating to the ordinary body cells other than egg and sperm; changes in these cells affect only the individual and are not inherited.
- • : The egg, sperm, and the cells that make them; changes in these cells can be passed to a person's children.
- • : An unintended effect when a drug or gene-editing tool acts on something other than its intended target, which can cause side effects.
- • : Agreeing to a treatment or study only after truly understanding its purpose, risks, benefits, and alternatives; the understanding, not the signature, is the ethics.
Use it now: Choose one decision option. Cite E1 and E3, then explain how the rule connects the evidence to your choice.
Go further, optional: The source links below are optional enrichment. Every fact required for today's local evidence decision appears in this lesson package.
A strong ethics CER names the benefit, the risk, and the reasoning that tips the balance one way.
Limit: E1 supplies context or an observation; it does not by itself establish the explanation.
carries risks we cannot fully predict, so a recommendation is only defensible when it names the benefit, names the risk, and shows the reasoning that tips the balance.
Limit: E2 is a teaching statement or comparison and must be checked against the task evidence.
You'll be able to write a complete, evidence-based CER.
Limit: E3 supports only the result or product criterion named here; it cannot justify a broader clinical or causal claim.
PLTW-GEND-2026-10-29 · Simulated classroom evidence scenario
Your role: medical interventions team member
Decision: Your team must decide what the evidence from ethics CER supports before submitting the claim-evidence-reasoning response named on the lesson page.
- • Select the option best supported by E1-E3.
- • Select a reasonable alternative and name the evidence it would require.
- • Delay the claim because the evidence does not distinguish the options.
Response: State one choice, cite at least two evidence IDs, explain the rule that connects them, and add one limitation. Submit it as the claim-evidence-reasoning response.
Claim ceiling: The supplied lesson evidence can support an observation, pattern, classroom mechanism, or next-step decision about ethics CER. It cannot by itself prove causation, establish a real clinical diagnosis, or justify action outside this classroom task.
Reason for review: Your team must decide what the evidence from ethics CER supports before submitting the claim-evidence-reasoning response named on the lesson page.
Context: A defensible recommendation does not pretend the risks away; it names the benefit, names the risk, and shows the reasoning that tips the balance, because honesty about uncertainty is what makes an argument trustworthy.
- • T1: Combine your vector chart and notes into the evidence for one CER.
- • T2: Write your final claim on whether the case patient should receive the .
- • T3: Support it with two pieces of evidence and reasoning that names one risk.
- • T4: Submit your ethics CER for the week-end summative.
- • E1: A strong ethics CER names the benefit, the risk, and the reasoning that tips the balance one way.
- • E2: carries risks we cannot fully predict, so a recommendation is only defensible when it names the benefit, names the risk, and shows the reasoning that tips the balance.
- • E3: You'll be able to write a complete, evidence-based CER.
Measurements: Use only the measurements, units, graph, or counts supplied in today's task. No additional patient measurement is implied.
Figure finding: Teaching diagram for ethics CER. Trace the labeled testing, treatment, or biological process and identify where evidence limits the decision. This is a teaching model, not patient or experimental data.
Uncertainty: This is a composite classroom scenario. Missing history, measurements, or confirmation tests remain unknown and limit the conclusion.
Mean = sum of values / number of values. Median = middle ordered value. Range = maximum - minimum.
For 2, 4, 4, and 10: mean = 20 / 4 = 5, median = 4, and range = 10 - 2 = 8.
Mean, median, and range keep the measurement unit. Order the values before finding the median.
Calculate the requested summary for today's supplied values, then write what it reveals and what it hides.
Students often think Students often think a strong recommendation means proving the therapy is completely safe, so admitting any risk must weaken their argument.. The trap: Naming the risk does not weaken your CER, because a recommendation that hides the downside is not defensible. The trap is thinking you must argue away every risk; the strongest ethics CER admits the and heritability risks and still shows why the benefit does or does not outweigh them.
Parallel case (not today's prompt): A patient carries a BRCA1 mutation that raises her lifetime breast cancer risk far above average. She could have a preventive (prophylactic) double mastectomy now, before any cancer appears, but the surgery is irreversible and carries its own risks. Should the care team recommend it? Study how this CER is built, then write your own on today's gene therapy question.\n\nClaim: The team should recommend the preventive double mastectomy for this BRCA1 carrier, because the benefit outweighs a risk we can prepare for.\n\nEvidence 1 (from my risk chart): A BRCA1 mutation raises lifetime breast cancer risk to roughly 55 to 72 percent, far above the general population rate of about 13 percent, and preventive mastectomy lowers that risk by about 90 percent or more.\n\nEvidence 2 (from my screening notes): The alternative, intensive surveillance with yearly MRI and mammography, catches cancer earlier but does not lower the chance of getting it, so it leaves the underlying high risk in place.\n\nReasoning that names the risk: The main risk is that surgery is permanent and can bring complications such as infection, loss of sensation, and the emotional weight of an irreversible change, and the patient might never have developed cancer at all. But because her inherited risk is so much higher than average, because surgery cuts that risk by roughly ninety percent, and because surveillance alone cannot lower the risk itself, the likely benefit of preventing a serious cancer tips the balance toward recommending the procedure, with counseling so the choice stays hers.\n\nBalance statement: I name the benefit (a large drop in a very high cancer risk), the risk (an irreversible surgery with real complications for a person who might never have gotten sick), and the reasoning (the size of the inherited risk plus the limits of surveillance) that tips it toward yes.
This model shows the level of evidence and organization needed to complete: Parallel worked CER modeling the unit synthesis format on a different bioethics case: a final claim on whether a BRCA1 carrier should have preventive surgery, two pieces of evidence, and reasoning that names one specific risk and balances it. Structurally identical to the gene therapy CER without answering that prompt.
- Write one defensible claim.
- Choose specific evidence that supports the claim.
- Explain the scientific rule that connects the evidence to the claim.
Keep the structure. Replace the question, facts, measurements, and evidence. Then recheck units, vocabulary, and whether the conclusion goes beyond the evidence.
Also due today: Submit your ethics CER to the class site.
- CER:
- Claim, Evidence, Reasoning: make a claim, back it with evidence, explain your reasoning.
- SOP:
- Standard Operating Procedure, the exact steps to follow (especially in a lab).
- Tracker:
- Your PLTW progress log where you record completed evidence.
- myPLTW:
- The PLTW course site where you do the online activities. Find it in Clever with your Microsoft sign-in, right next to Schoology.
Tap the speaker to hear a term. Add two of these to your notebook glossary with a definition and an example in your own words.
Pick just 2 or 3 words from today and make them yours: write what each one means in your own words, name the context clue or evidence that helped, then give one example from what you actually did in Gene therapy ethics CER. Try your own words first; the glossary is there if you get stuck. This is voluntary and counts as extra credit, so keep it short.
Saved on this device. Show Mr. Mendoza or add these to your notebook glossary to claim the extra credit.
Classroom documents for this lesson are posted in Schoology. Open Clever, then Schoology, and find each one by the name shown on its card.
Use this if you were absent, got stuck, or need another pass before you submit the lesson artifact.
Placement rationale
Matched , , reproductive ethics by path:Medical-Interventions/Unit-2_How-to-Screen-Your-Genes/2.2_Our-Genetic-Future; keywords:gene therapy, reproductive. Score 138. Visibility: student-schoology (student-facing resource; link through Schoology rather than local path).
Open this when the class reaches this activity and use it to complete the required lesson artifact.
Placement rationale
Matched , , reproductive ethics by path:Medical-Interventions/Unit-2_How-to-Screen-Your-Genes/2.2_Our-Genetic-Future; keywords:ethics, reproductive. Score 138. Visibility: student-schoology (student-facing resource; link through Schoology rather than local path).
Use this after the required lesson work when you are ready for a harder application or a deeper connection.
Placement rationale
Matched , , reproductive ethics by path:Medical-Interventions/Unit-2_How-to-Screen-Your-Genes/00_Unit-Overview; keywords:gene therapy, crispr. Score 134. Visibility: student-schoology (student-facing resource; link through Schoology rather than local path).
How to get there: open Clever and sign in with your Microsoft (district) account. Both myPLTW and Schoology are in Clever. Do the activity in myPLTW. Turn the work in on this site or hand it to Mr. Mendoza, because that is the step that counts as submitted. Schoology only shows your report-card grade later.
Check yourself · commit, then reveal▸
Claim ceiling for this check: The supplied lesson evidence can support an observation, pattern, classroom mechanism, or next-step decision about ethics CER. It cannot by itself prove causation, establish a real clinical diagnosis, or justify action outside this classroom task.
A classmate writes a gene therapy CER that lists only the benefits and never mentions off-target or heritability risk. Why is that not a defensible ethics recommendation?
Write an answer and pick a confidence to unlock the key.
Fast retrieval with instant answers, not the commit-then-reveal check above. Try each from memory first: write what you remember about the earlier units, then check yourself here.
Go further and get help▸
What today's skills lead to. These are real health-science careers this course builds toward. Tap one to see, on the US Department of Labor's O*NET site, what the job actually involves, what it pays, and how fast it is growing.
Today is individual work you can do from home: complete the same target above, then submit your CER.
Open the drop folderTurn this in at the drop folder with your district Microsoft sign-in, or hand it to Mr. Mendoza in class. Both count as submitted. Doing the activity in myPLTW does not.
Class still runs. Complete the online activity above (it's self-guided). Need the concept taught without a teacher? Use this authoritative explainer:
MedlinePlus: What is gene therapy?You've passed Unit 2, so the optional extra-credit track is open. Complete reserved-unit work from home, including virtual labs, for extra credit. Each item shows its correct submission route.
Open the extra-credit track- CompleteEvery required part of the artifact is present, nothing left blank.
- AccurateThe science and the data are correct and match the evidence.
- Scientific reasoningYou explain your claim with evidence and reasoning (CER), not just an answer.
- Professional communicationClear, organized, labeled, and written the way a clinician or scientist would.
- SubmittedTurned in the right way, on the class site or handed to Mr. Mendoza in class, and confirmed. Not in Schoology: that is where the report-card grade appears later.